Cargando…
Amisulpride Augmentation for Clozapine-Refractory Positive Symptoms: Additional Benefit in Reducing Hypersialorrhea
One-third to half of patients taking clozapine suffer from refractory symptoms despite adequate treatment. Among other adverse effects, clozapine-induced hypersalivation (CIH) occurs in approximately half of all patients. This is a case of a 30-year-old male with refractory schizophrenia; in this pa...
Autores principales: | Bogorni, Fabiani, Moreira, Frederico Fernandes, Pimentel, Eduardo Mylius, Grohs, Géder Evandro Motta, Diaz, Alexandre Paim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370110/ https://www.ncbi.nlm.nih.gov/pubmed/25838958 http://dx.doi.org/10.1155/2015/408179 |
Ejemplares similares
-
Augmenting amisulpride with clozapine had led to unmasking of akathisia
por: Ray, Anirban, et al.
Publicado: (2012) -
Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial
por: Barnes, Thomas R.E., et al.
Publicado: (2018) -
Title- Augmenting Amisulpride With Clozapine Leading To Akathisia: A Case Report
Publicado: (2022) -
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial
por: Zhu, Ming-Huan, et al.
Publicado: (2022) -
Augmentation strategies for treatment-refractory clozapine patients
por: Freudenreich, O.
Publicado: (2021)